Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1026706.RApX0QA4de7FTUZCoV9b2GRGg8lOznQCnHwSn5b8wjQBM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1026706.RApX0QA4de7FTUZCoV9b2GRGg8lOznQCnHwSn5b8wjQBM130_assertion type Assertion NP1026706.RApX0QA4de7FTUZCoV9b2GRGg8lOznQCnHwSn5b8wjQBM130_head.
- NP1026706.RApX0QA4de7FTUZCoV9b2GRGg8lOznQCnHwSn5b8wjQBM130_assertion description "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1026706.RApX0QA4de7FTUZCoV9b2GRGg8lOznQCnHwSn5b8wjQBM130_provenance.
- NP1026706.RApX0QA4de7FTUZCoV9b2GRGg8lOznQCnHwSn5b8wjQBM130_assertion evidence source_evidence_literature NP1026706.RApX0QA4de7FTUZCoV9b2GRGg8lOznQCnHwSn5b8wjQBM130_provenance.
- NP1026706.RApX0QA4de7FTUZCoV9b2GRGg8lOznQCnHwSn5b8wjQBM130_assertion SIO_000772 23135268 NP1026706.RApX0QA4de7FTUZCoV9b2GRGg8lOznQCnHwSn5b8wjQBM130_provenance.
- NP1026706.RApX0QA4de7FTUZCoV9b2GRGg8lOznQCnHwSn5b8wjQBM130_assertion wasDerivedFrom befree-2016 NP1026706.RApX0QA4de7FTUZCoV9b2GRGg8lOznQCnHwSn5b8wjQBM130_provenance.
- NP1026706.RApX0QA4de7FTUZCoV9b2GRGg8lOznQCnHwSn5b8wjQBM130_assertion wasGeneratedBy ECO_0000203 NP1026706.RApX0QA4de7FTUZCoV9b2GRGg8lOznQCnHwSn5b8wjQBM130_provenance.